Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 16 entries
Sorted by: Best Match Show Resources per page
Spectral karyotyping and SNP microarray analysis define uniparental disomy (UPD) as a novel mutational mechanism in MSI- and CSI-colorectal cancers.

Cellular oncology : the official journal of the International Society for Cellular Oncology

Melcher R, Zopf W, Hartmann E, Rosenwald A, Hoehn H, Schmid M, Kudlich T, Scheurlen M, Luehrs H.
PMID: 18936529
Cell Oncol. 2008;30(6):507. doi: 10.3233/clo-2008-0452.

No abstract available.

Cite
Melcher R, Zopf W, Hartmann E, et al. Spectral karyotyping and SNP microarray analysis define uniparental disomy (UPD) as a novel mutational mechanism in MSI- and CSI-colorectal cancers. Cell Oncol. 2008;30(6):507doi: 10.3233/clo-2008-0452.
Melcher, R., Zopf, W., Hartmann, E., Rosenwald, A., Hoehn, H., Schmid, M., Kudlich, T., Scheurlen, M., & Luehrs, H. (2008). Spectral karyotyping and SNP microarray analysis define uniparental disomy (UPD) as a novel mutational mechanism in MSI- and CSI-colorectal cancers. Cellular oncology : the official journal of the International Society for Cellular Oncology, 30(6), 507. https://doi.org/10.3233/clo-2008-0452
Melcher, Ralph, et al. "Spectral karyotyping and SNP microarray analysis define uniparental disomy (UPD) as a novel mutational mechanism in MSI- and CSI-colorectal cancers." Cellular oncology : the official journal of the International Society for Cellular Oncology vol. 30,6 (2008): 507. doi: https://doi.org/10.3233/clo-2008-0452
Melcher R, Zopf W, Hartmann E, Rosenwald A, Hoehn H, Schmid M, Kudlich T, Scheurlen M, Luehrs H. Spectral karyotyping and SNP microarray analysis define uniparental disomy (UPD) as a novel mutational mechanism in MSI- and CSI-colorectal cancers. Cell Oncol. 2008;30(6):507. doi: 10.3233/clo-2008-0452. PMID: 18936529; PMCID: PMC4618808.
Copy Download .nbib Format: NLM
Wnt/β-Catenin Signaling Regulates CXCR4 Expression and [.

Diagnostics (Basel, Switzerland)

Weich A, Rogoll D, Gawlas S, Mayer L, Weich W, Pongracz J, Kudlich T, Meining A, Scheurlen M.
PMID: 33671498
Diagnostics (Basel). 2021 Feb 22;11(2). doi: 10.3390/diagnostics11020367.

Loss of Somatostatin Receptor 2 (SSTR2) expression and rising CXC Chemokine Receptor Type 4 (CXCR4) expression are associated with dedifferentiation in neuroendocrine tumors (NET). In NET, CXCR4 expression is associated with enhanced metastatic and invasive potential and worse prognosis...

Cite
Weich A, Rogoll D, Gawlas S, et al. Wnt/β-Catenin Signaling Regulates CXCR4 Expression and [. Diagnostics (Basel). 2021;11(2)doi: 10.3390/diagnostics11020367.
Weich, A., Rogoll, D., Gawlas, S., Mayer, L., Weich, W., Pongracz, J., Kudlich, T., Meining, A., & Scheurlen, M. (2021). Wnt/β-Catenin Signaling Regulates CXCR4 Expression and [. Diagnostics (Basel, Switzerland), 11(2), . https://doi.org/10.3390/diagnostics11020367
Weich, Alexander, et al. "Wnt/β-Catenin Signaling Regulates CXCR4 Expression and [." Diagnostics (Basel, Switzerland) vol. 11,2 (2021). doi: https://doi.org/10.3390/diagnostics11020367
Weich A, Rogoll D, Gawlas S, Mayer L, Weich W, Pongracz J, Kudlich T, Meining A, Scheurlen M. Wnt/β-Catenin Signaling Regulates CXCR4 Expression and [. Diagnostics (Basel). 2021 Feb 22;11(2). doi: 10.3390/diagnostics11020367. PMID: 33671498; PMCID: PMC7926465.
Copy Download .nbib Format: NLM
State-of-the-art surgery for Crohn's disease: Part I-small intestine/ileal disease.

Langenbeck's archives of surgery

Kavalukas SL, Scheurlen KM, Galandiuk S.
PMID: 34738167
Langenbecks Arch Surg. 2021 Nov 04; doi: 10.1007/s00423-021-02324-4. Epub 2021 Nov 04.

The management of Crohn's disease has evolved significantly over the past 20 years. The arrival of biologic therapies has altered not only the management and outcomes but also rates for refractory disease requiring surgery. New surgical techniques have paralleled...

Cite
Kavalukas SL, Scheurlen KM, Galandiuk S. State-of-the-art surgery for Crohn's disease: Part I-small intestine/ileal disease. Langenbecks Arch Surg. 2021;doi: 10.1007/s00423-021-02324-4.
Kavalukas, S. L., Scheurlen, K. M., & Galandiuk, S. (2021). State-of-the-art surgery for Crohn's disease: Part I-small intestine/ileal disease. Langenbeck's archives of surgery, . https://doi.org/10.1007/s00423-021-02324-4
Kavalukas, Sandra L, et al. "State-of-the-art surgery for Crohn's disease: Part I-small intestine/ileal disease." Langenbeck's archives of surgery vol. (2021). doi: https://doi.org/10.1007/s00423-021-02324-4
Kavalukas SL, Scheurlen KM, Galandiuk S. State-of-the-art surgery for Crohn's disease: Part I-small intestine/ileal disease. Langenbecks Arch Surg. 2021 Nov 04; doi: 10.1007/s00423-021-02324-4. Epub 2021 Nov 04. PMID: 34738167.
Copy Download .nbib Format: NLM
Itaconate and leptin affecting PPARγ in M2 macrophages: A potential link to early-onset colorectal cancer.

Surgery

Scheurlen KM, Snook DL, Walter MN, Cook CN, Fiechter CR, Pan J, Beal RJ, Galandiuk S.
PMID: 34876290
Surgery. 2021 Dec 04; doi: 10.1016/j.surg.2021.10.054. Epub 2021 Dec 04.

BACKGROUND: Along with the rising incidence of obesity, there has been an increase in patients diagnosed with early-onset colorectal cancer (

Cite
Scheurlen KM, Snook DL, Walter MN, et al. Itaconate and leptin affecting PPARγ in M2 macrophages: A potential link to early-onset colorectal cancer. Surgery. 2021;doi: 10.1016/j.surg.2021.10.054.
Scheurlen, K. M., Snook, D. L., Walter, M. N., Cook, C. N., Fiechter, C. R., Pan, J., Beal, R. J., & Galandiuk, S. (2021). Itaconate and leptin affecting PPARγ in M2 macrophages: A potential link to early-onset colorectal cancer. Surgery, . https://doi.org/10.1016/j.surg.2021.10.054
Scheurlen, Katharina M, et al. "Itaconate and leptin affecting PPARγ in M2 macrophages: A potential link to early-onset colorectal cancer." Surgery vol. (2021). doi: https://doi.org/10.1016/j.surg.2021.10.054
Scheurlen KM, Snook DL, Walter MN, Cook CN, Fiechter CR, Pan J, Beal RJ, Galandiuk S. Itaconate and leptin affecting PPARγ in M2 macrophages: A potential link to early-onset colorectal cancer. Surgery. 2021 Dec 04; doi: 10.1016/j.surg.2021.10.054. Epub 2021 Dec 04. PMID: 34876290.
Copy Download .nbib Format: NLM
Combined Neurophysiologic and Neuroimaging Approach to Reveal the Structure-Function Paradox in Cervical Myelopathy.

Neurology

Scheuren PS, David G, Kipling Kramer JL, Jutzeler CR, Hupp M, Freund P, Curt A, Hubli M, Rosner J.
PMID: 34380751
Neurology. 2021 Aug 11; doi: 10.1212/WNL.0000000000012643. Epub 2021 Aug 11.

OBJECTIVE: To explore the so-called "structure-function paradox" in individuals with focal spinal lesions by means of tract-specific MRI coupled with multi-modal evoked potentials and quantitative sensory testing.METHODS: Individuals with signs and symptoms attributable to cervical myelopathy (i.e., no evidence...

Cite
Scheuren PS, David G, Kipling Kramer JL, et al. Combined Neurophysiologic and Neuroimaging Approach to Reveal the Structure-Function Paradox in Cervical Myelopathy. Neurology. 2021;doi: 10.1212/WNL.0000000000012643.
Scheuren, P. S., David, G., Kipling Kramer, J. L., Jutzeler, C. R., Hupp, M., Freund, P., Curt, A., Hubli, M., & Rosner, J. (2021). Combined Neurophysiologic and Neuroimaging Approach to Reveal the Structure-Function Paradox in Cervical Myelopathy. Neurology, . https://doi.org/10.1212/WNL.0000000000012643
Scheuren, Paulina Simonne, et al. "Combined Neurophysiologic and Neuroimaging Approach to Reveal the Structure-Function Paradox in Cervical Myelopathy." Neurology vol. (2021). doi: https://doi.org/10.1212/WNL.0000000000012643
Scheuren PS, David G, Kipling Kramer JL, Jutzeler CR, Hupp M, Freund P, Curt A, Hubli M, Rosner J. Combined Neurophysiologic and Neuroimaging Approach to Reveal the Structure-Function Paradox in Cervical Myelopathy. Neurology. 2021 Aug 11; doi: 10.1212/WNL.0000000000012643. Epub 2021 Aug 11. PMID: 34380751.
Copy Download .nbib Format: NLM
A Systematic Review of Safety Reporting in Acute Spinal Cord Injury Clinical Trials: Challenges and Recommendations.

Journal of neurotrauma

Aspinall P, Harrison L, Scheuren P, Cragg JJ, Ferguson AR, Guest JD, Hsieh J, Jones L, Kirshblum S, Lammertse D, Kwon BK, Kramer JLK.
PMID: 33899507
J Neurotrauma. 2021 Aug 01;38(15):2047-2054. doi: 10.1089/neu.2020.7540. Epub 2021 Jun 03.

Accurate safety information in published clinical trials guides the assessment of risk-benefit, as well as the design of future clinical trials. Comprehensive reporting of adverse events, toxicity, and discontinuations from acute spinal cord injury clinical trials is an essential...

Cite
Aspinall P, Harrison L, Scheuren P, et al. A Systematic Review of Safety Reporting in Acute Spinal Cord Injury Clinical Trials: Challenges and Recommendations. J Neurotrauma. 2021;38(15):2047-2054doi: 10.1089/neu.2020.7540.
Aspinall, P., Harrison, L., Scheuren, P., Cragg, J. J., Ferguson, A. R., Guest, J. D., Hsieh, J., Jones, L., Kirshblum, S., Lammertse, D., Kwon, B. K., & Kramer, J. L. K. (2021). A Systematic Review of Safety Reporting in Acute Spinal Cord Injury Clinical Trials: Challenges and Recommendations. Journal of neurotrauma, 38(15), 2047-2054. https://doi.org/10.1089/neu.2020.7540
Aspinall, Paul, et al. "A Systematic Review of Safety Reporting in Acute Spinal Cord Injury Clinical Trials: Challenges and Recommendations." Journal of neurotrauma vol. 38,15 (2021): 2047-2054. doi: https://doi.org/10.1089/neu.2020.7540
Aspinall P, Harrison L, Scheuren P, Cragg JJ, Ferguson AR, Guest JD, Hsieh J, Jones L, Kirshblum S, Lammertse D, Kwon BK, Kramer JLK. A Systematic Review of Safety Reporting in Acute Spinal Cord Injury Clinical Trials: Challenges and Recommendations. J Neurotrauma. 2021 Aug 01;38(15):2047-2054. doi: 10.1089/neu.2020.7540. Epub 2021 Jun 03. PMID: 33899507.
Copy Download .nbib Format: NLM
A highly crystalline anthracene-based MOF-74 series featuring electrical conductivity and luminescence.

Nanoscale

Scheurle PI, Mähringer A, Jakowetz AC, Hosseini P, Richter AF, Wittstock G, Medina DD, Bein T.
PMID: 31660561
Nanoscale. 2019 Nov 21;11(43):20949-20955. doi: 10.1039/c9nr05431f. Epub 2019 Oct 29.

Recently, a small group of metal-organic frameworks (MOFs) has been discovered featuring substantial charge transport properties and electrical conductivity, hence promising to broaden the scope of potential MOF applications in fields such as batteries, fuel cells and supercapacitors. In...

Cite
Scheurle PI, Mähringer A, Jakowetz AC, et al. A highly crystalline anthracene-based MOF-74 series featuring electrical conductivity and luminescence. Nanoscale. 2019;11(43):20949-20955doi: 10.1039/c9nr05431f.
Scheurle, P. I., Mähringer, A., Jakowetz, A. C., Hosseini, P., Richter, A. F., Wittstock, G., Medina, D. D., & Bein, T. (2019). A highly crystalline anthracene-based MOF-74 series featuring electrical conductivity and luminescence. Nanoscale, 11(43), 20949-20955. https://doi.org/10.1039/c9nr05431f
Scheurle, Patricia I, et al. "A highly crystalline anthracene-based MOF-74 series featuring electrical conductivity and luminescence." Nanoscale vol. 11,43 (2019): 20949-20955. doi: https://doi.org/10.1039/c9nr05431f
Scheurle PI, Mähringer A, Jakowetz AC, Hosseini P, Richter AF, Wittstock G, Medina DD, Bein T. A highly crystalline anthracene-based MOF-74 series featuring electrical conductivity and luminescence. Nanoscale. 2019 Nov 21;11(43):20949-20955. doi: 10.1039/c9nr05431f. Epub 2019 Oct 29. PMID: 31660561.
Copy Download .nbib Format: NLM
Clinical trials and tribulations: lessons from spinal cord injury studies registered on ClinicalTrials.gov.

Spinal cord

Warner FM, Bailey NG, Scheuren PS, Lütolf R, McGregor R, Banga R, Hsieh JTC, Kramer JLK.
PMID: 34480090
Spinal Cord. 2021 Dec;59(12):1256-1260. doi: 10.1038/s41393-021-00699-1. Epub 2021 Sep 03.

STUDY DESIGN: Article.OBJECTIVE: ClinicalTrials.gov is an online trial registry that provides public access to information on past, present, and future clinical trials. While increasing transparency in research, the quality of the information provided in trial registrations is highly variable....

Cite
Warner FM, Bailey NG, Scheuren PS, et al. Clinical trials and tribulations: lessons from spinal cord injury studies registered on ClinicalTrials.gov. Spinal Cord. 2021;59(12):1256-1260doi: 10.1038/s41393-021-00699-1.
Warner, F. M., Bailey, N. G., Scheuren, P. S., Lütolf, R., McGregor, R., Banga, R., Hsieh, J. T. C., & Kramer, J. L. K. (2021). Clinical trials and tribulations: lessons from spinal cord injury studies registered on ClinicalTrials.gov. Spinal cord, 59(12), 1256-1260. https://doi.org/10.1038/s41393-021-00699-1
Warner, Freda M, et al. "Clinical trials and tribulations: lessons from spinal cord injury studies registered on ClinicalTrials.gov." Spinal cord vol. 59,12 (2021): 1256-1260. doi: https://doi.org/10.1038/s41393-021-00699-1
Warner FM, Bailey NG, Scheuren PS, Lütolf R, McGregor R, Banga R, Hsieh JTC, Kramer JLK. Clinical trials and tribulations: lessons from spinal cord injury studies registered on ClinicalTrials.gov. Spinal Cord. 2021 Dec;59(12):1256-1260. doi: 10.1038/s41393-021-00699-1. Epub 2021 Sep 03. PMID: 34480090.
Copy Download .nbib Format: NLM
Increased Expression of Long Non-coding RNA H19 is Associated With Colon Cancer Recurrence.

The Journal of surgical research

O'Brien SJ, Scheurlen K, Rochet A, Fiechter C, Paas M, Pan J, Rai SN, Galandiuk S.
PMID: 34520983
J Surg Res. 2021 Sep 11;269:59-68. doi: 10.1016/j.jss.2021.08.004. Epub 2021 Sep 11.

BACKGROUND: Colon cancer is a leading cause of cancer-related death. Long non-coding (Lnc) RNAs are critical mediators of tumor biology. H19 is a well-characterized lncRNA involved in p53 regulation and cancer progression. A specific colon cancer data set was...

Cite
O'Brien SJ, Scheurlen K, Rochet A, et al. Increased Expression of Long Non-coding RNA H19 is Associated With Colon Cancer Recurrence. J Surg Res. 2021;269:59-68doi: 10.1016/j.jss.2021.08.004.
O'Brien, S. J., Scheurlen, K., Rochet, A., Fiechter, C., Paas, M., Pan, J., Rai, S. N., & Galandiuk, S. (2021). Increased Expression of Long Non-coding RNA H19 is Associated With Colon Cancer Recurrence. The Journal of surgical research, 26959-68. https://doi.org/10.1016/j.jss.2021.08.004
O'Brien, Stephen J, et al. "Increased Expression of Long Non-coding RNA H19 is Associated With Colon Cancer Recurrence." The Journal of surgical research vol. 269 (2021): 59-68. doi: https://doi.org/10.1016/j.jss.2021.08.004
O'Brien SJ, Scheurlen K, Rochet A, Fiechter C, Paas M, Pan J, Rai SN, Galandiuk S. Increased Expression of Long Non-coding RNA H19 is Associated With Colon Cancer Recurrence. J Surg Res. 2021 Sep 11;269:59-68. doi: 10.1016/j.jss.2021.08.004. Epub 2021 Sep 11. PMID: 34520983.
Copy Download .nbib Format: NLM
Comorbidities as an Indication for Metabolic Surgery.

Visceral medicine

Schwarz AC, Billeter AT, Scheurlen KM, Blüher M, Müller-Stich BP.
PMID: 30498706
Visc Med. 2018 Oct;34(5):381-387. doi: 10.1159/000493291. Epub 2018 Oct 28.

Metabolic diseases, comprising type 2 diabetes mellitus (T2DM), dyslipidemia, and non-alcoholic steatohepatitis (NASH), are rapidly increasing worldwide. Conservative medical therapy, including the newly available drugs, has only limited effects and does neither influence survival or the development of micro-...

Cite
Schwarz AC, Billeter AT, Scheurlen KM, et al. Comorbidities as an Indication for Metabolic Surgery. Visc Med. 2018;34(5):381-387doi: 10.1159/000493291.
Schwarz, A. C., Billeter, A. T., Scheurlen, K. M., Blüher, M., & Müller-Stich, B. P. (2018). Comorbidities as an Indication for Metabolic Surgery. Visceral medicine, 34(5), 381-387. https://doi.org/10.1159/000493291
Schwarz, Anne-Catherine, et al. "Comorbidities as an Indication for Metabolic Surgery." Visceral medicine vol. 34,5 (2018): 381-387. doi: https://doi.org/10.1159/000493291
Schwarz AC, Billeter AT, Scheurlen KM, Blüher M, Müller-Stich BP. Comorbidities as an Indication for Metabolic Surgery. Visc Med. 2018 Oct;34(5):381-387. doi: 10.1159/000493291. Epub 2018 Oct 28. PMID: 30498706; PMCID: PMC6257097.
Copy Download .nbib Format: NLM
CXCR4-Directed PET/CT in Patients with Newly Diagnosed Neuroendocrine Carcinomas.

Diagnostics (Basel, Switzerland)

Weich A, Werner RA, Buck AK, Hartrampf PE, Serfling SE, Scheurlen M, Wester HJ, Meining A, Kircher S, Higuchi T, Pomper MG, Rowe SP, Lapa C, Kircher M.
PMID: 33805264
Diagnostics (Basel). 2021 Mar 29;11(4). doi: 10.3390/diagnostics11040605.

We aimed to elucidate the diagnostic potential of the C-X-C motif chemokine receptor 4 (CXCR4)-directed positron emission tomography (PET) tracer

Cite
Weich A, Werner RA, Buck AK, et al. CXCR4-Directed PET/CT in Patients with Newly Diagnosed Neuroendocrine Carcinomas. Diagnostics (Basel). 2021;11(4)doi: 10.3390/diagnostics11040605.
Weich, A., Werner, R. A., Buck, A. K., Hartrampf, P. E., Serfling, S. E., Scheurlen, M., Wester, H. J., Meining, A., Kircher, S., Higuchi, T., Pomper, M. G., Rowe, S. P., Lapa, C., & Kircher, M. (2021). CXCR4-Directed PET/CT in Patients with Newly Diagnosed Neuroendocrine Carcinomas. Diagnostics (Basel, Switzerland), 11(4), . https://doi.org/10.3390/diagnostics11040605
Weich, Alexander, et al. "CXCR4-Directed PET/CT in Patients with Newly Diagnosed Neuroendocrine Carcinomas." Diagnostics (Basel, Switzerland) vol. 11,4 (2021). doi: https://doi.org/10.3390/diagnostics11040605
Weich A, Werner RA, Buck AK, Hartrampf PE, Serfling SE, Scheurlen M, Wester HJ, Meining A, Kircher S, Higuchi T, Pomper MG, Rowe SP, Lapa C, Kircher M. CXCR4-Directed PET/CT in Patients with Newly Diagnosed Neuroendocrine Carcinomas. Diagnostics (Basel). 2021 Mar 29;11(4). doi: 10.3390/diagnostics11040605. PMID: 33805264; PMCID: PMC8067200.
Copy Download .nbib Format: NLM
[Value of galactography for the diagnostic work-up of pathological nipple discharge in multimodal breast diagnostics : Part 1: An online survey among German breast care centers.].

Der Radiologe

Scheurlen K, Schnitzer A, Krammer J, Kaiser C, Schönberg SO, Wasser K.
PMID: 24233401
Radiologe. 2013 Nov 15; doi: 10.1007/s00117-013-2572-8. Epub 2013 Nov 15.

PURPOSE: Galactography has been used in cases of pathological discharge for decades. Meanwhile other methods, such as high-resolution ultrasound (US) and magnetic resonance mammography (MRM) have been established for modern multimodal breast imaging. A survey among certified German breast...

Cite
Scheurlen K, Schnitzer A, Krammer J, et al. Stellenwert der Galaktographie zur Abklärung pathologischer Sekretion in der komplementären Mammadiagnostik : Teil 1: Eine Onlineumfrage an den deutschen Brustzentren. [Value of galactography for the diagnostic work-up of pathological nipple discharge in multimodal breast diagnostics : Part 1: An online survey among German breast care centers.]. Radiologe. 2013;doi: 10.1007/s00117-013-2572-8.
Scheurlen, K., Schnitzer, A., Krammer, J., Kaiser, C., Schönberg, S. O., & Wasser, K. (2013). Stellenwert der Galaktographie zur Abklärung pathologischer Sekretion in der komplementären Mammadiagnostik : Teil 1: Eine Onlineumfrage an den deutschen Brustzentren. [Value of galactography for the diagnostic work-up of pathological nipple discharge in multimodal breast diagnostics : Part 1: An online survey among German breast care centers.]. Der Radiologe, . https://doi.org/10.1007/s00117-013-2572-8
Scheurlen, K, et al. "Stellenwert der Galaktographie zur Abklärung pathologischer Sekretion in der komplementären Mammadiagnostik : Teil 1: Eine Onlineumfrage an den deutschen Brustzentren." [Value of galactography for the diagnostic work-up of pathological nipple discharge in multimodal breast diagnostics : Part 1: An online survey among German breast care centers.]. Der Radiologe vol. (2013). doi: https://doi.org/10.1007/s00117-013-2572-8
Scheurlen K, Schnitzer A, Krammer J, Kaiser C, Schönberg SO, Wasser K. Stellenwert der Galaktographie zur Abklärung pathologischer Sekretion in der komplementären Mammadiagnostik : Teil 1: Eine Onlineumfrage an den deutschen Brustzentren. [Value of galactography for the diagnostic work-up of pathological nipple discharge in multimodal breast diagnostics : Part 1: An online survey among German breast care centers.]. Radiologe. 2013 Nov 15; doi: 10.1007/s00117-013-2572-8. Epub 2013 Nov 15. German. PMID: 24233401.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 16 entries